Celon Pharma's generic semaglutide drug matches Ozempic in early study, shares jump - Reuters
Celon Pharma's generic semaglutide drug matches Ozempic in early study, shares jump Reuters
Coverage by Political Leaning
See how different sides of the spectrum reported this story
All Coverage
<a href="https://news.google.com/rss/articles/CBMiywFBVV95cUxOdmZqUWR5MGt1TzZHMzk1SGs0dkZ3Y2R4Q0JLMWJVSENHbkM5QmlfMzliclZTcVpFWnpzLWllbG1aeUxZZXlMWUxqSF9xN0JfRWZDazhkYXlyWUNlMDdITXlzUTZyMGNZRW9zZHNFQkU5REtrZFBlRkp0V3cyMkZIQkVEbWhJck5FTS0yM044RGZkWURIVy1nSGxPQmRGakNHZTVmdVBpeHlvaHdnM0NYNi1Qal93YjU4UmdfMk9CVUtTRmQtNG5iMEVXZw?oc=5" target="_blank">Celon Pharma's generic semaglutide drug matches Ozempic in early study, shares jump</a> <font color="#6f6f6f">Reuters</font>
Similar Stories
Related coverage based on topic and tags
Argenx discontinues Vyvgart study in Sjögren's disease, shares tumble - Reuters
Argenx discontinues Vyvgart study in Sjögren's disease, shares tumble Reuters
October 8, 2026 at 08:49 PMTeva wins FDA approval for monthly schizophrenia injection Weltruza - Reuters
Teva wins FDA approval for monthly schizophrenia injection Weltruza Reuters
October 9, 2026 at 11:47 AMHalozyme wins court order to block Merck's injected Keytruda in select European markets - Reuters
Halozyme wins court order to block Merck's injected Keytruda in select European markets Reuters
October 7, 2026 at 05:03 PMWHO endorses lifestyle changes over GLP-1 drugs in child obesity fight - Reuters
WHO endorses lifestyle changes over GLP-1 drugs in child obesity fight Reuters
October 7, 2026 at 07:39 AMPepsiCo running out of time to meet Elliott-inspired targets as GLP-1 threat intensifies - Reuters
PepsiCo running out of time to meet Elliott-inspired targets as GLP-1 threat intensifies Reuters
October 7, 2026 at 11:36 AMNvidia-backed Iambic Therapeutics launches IPO as biotechs buck market gloom - Reuters
Nvidia-backed Iambic Therapeutics launches IPO as biotechs buck market gloom Reuters
October 8, 2026 at 06:18 PM